JLR Selects Alkegen to Bring Advanced Thermal Protection to Their Next Generation Battery Systems
Alkegen, a high-performance specialty materials company pioneering innovative solutions for the battery industry, announced today that JLR has selected Alkegen’s new range of anti-thermal propagation products to bring the ultimate in thermal protection to JLR’s next generation electric vehicles.
The new product line introduces a range of flexible advanced solutions that provide multiple levels of protection throughout the battery. The versatility of these products allows for seamless integration into diverse applications within battery design, showcasing its adaptability across different electric vehicle models.
"We are delighted to partner with JLR in championing its ambitious Reimagine strategy and our shared goal to create a more sustainable world,” said Alkegen’s Battery Group President Gaetan Borgers. “We look forward to collaborating with both JLR and its tiered suppliers to deliver both superior thermal protection and unmatched flexibility to its product design.”
Alkegen is set to play a vital role in supporting JLR's design process and assisting in material selection for anti-thermal propagation management within the battery pack. Production for the new product line will begin ramping up with immediate effect, aligning with the timeline for integration into JLR's future EV programs.
Alkegen has provided thermal management, sustainability and driver safety solutions to major car OEMs for decades. Alkegen continues to build a broad portfolio of battery material technologies to improve lithium-based battery pack safety while helping to extend battery life and accelerate charging time. To learn more about Alkegen’s recent innovations in the EV battery market, visit www.alkegen.com/battery.
For more information about Alkegen, visit www.alkegen.com.
About Alkegen
Alkegen creates high performance specialty materials used in advanced applications including electric vehicles, energy storage, filtration, fire protection and high-temperature insulation, among many others. Employing a vertically integrated approach across our broad array of technology platforms, Alkegen is committed to achieving energy efficiency, pollution reduction, and enhanced safety for individuals, structures, and equipment. Our overarching mission is to help the world breathe easier, live greener and go further than ever before. Alkegen has 60+ manufacturing facilities operating in 12 countries and employs 7,500+ employees globally. More information is available at www.alkegen.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240417516694/en/
Contact information
Kristen Weiss
kweiss@alkegen.com
352.424.3169
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Commnet Broadband transforms in-home connectivity across rural American Southwest with Adtran Intellifi ®30.4.2024 14:00:00 CEST | Press release
Adtran today announced that Commnet Broadband is leveraging Intellifi® as part of its Mosaic One software-as-a-service (SaaS) solution to enhance in-home connectivity as the service provider scales across the American Southwest. The cloud-managed Wi-Fi solution will enable Commnet Broadband to deliver a seamless, always-on mesh Wi-Fi experience, boosting subscriber satisfaction while driving new efficiencies. With a strong commitment to digital inclusion, Commnet Broadband is extending its reach into more underserved rural communities, connecting them with reliable and high-quality internet services. Deploying Mosaic One for remote service activation and troubleshooting, along with Intellifi® for AI-driven insights and complete control over the home Wi-Fi environment, enables the company to efficiently manage its expansive and diverse network infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240430732731/en/ Adt
Esri Releases Latest Land Cover Map with Updated Sentinel-2 Satellite Data30.4.2024 14:00:00 CEST | Press release
Esri, the global leader in location intelligence, in its partnership with Impact Observatory, has released an updated global land-use/land-cover map of the world based on the most up-to-date 10-meter Sentinel-2 satellite data. In the update, the Sentinel-2 10m Land Use/Land Cover Time Series includes new data from 2023, expanding the series to include global coverage from 2017-2023. Organizations around the world use updated land-cover maps to inform policy and land management decisions around issues like sustainable development. The update has occurred every year since 2017. Year-over-year changes in the maps can be key indicators that help analysts and decision-makers better understand the impacts of earth processes and human activity on the environment. This in turn can inform sustainable land management policies. "Users have the option to make year-over-year comparisons in global land cover today and into the future," said Sean Breyer, Esri program manager for ArcGIS Living Atlas o
Airgain and Mouser Electronics Sign Agreement to Provide Airgain Products to Design Engineers Globally30.4.2024 14:00:00 CEST | Press release
Airgain, Inc. (NASDAQ: AIRG), a leading provider of wireless connectivity solutions that creates and delivers embedded components, external antennas, and integrated systems across the globe, announced an agreement to distribute its wireless and IoT products through Mouser Electronics, an online electronic component distributor that serves the global electronic design engineer and buyer community. The new agreement will make Airgain’s innovative NimbeLink embedded modems, antennas, and other wireless products more broadly available to design engineers looking to simplify wireless connectivity in their new product designs. “Mouser allows us to expand our reach to embedded design engineers and give them more channels and resources, especially at the design and testing phases,” said Lance Laing, Vice President of US Sales for Airgain. “Ultimately, Airgain wants to be found where the design engineer is looking, and Mouser, one of the world’s largest online distributors of electronic compone
TriLink BioTechnologies ® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap ® mRNA Capping Technology30.4.2024 13:31:00 CEST | Press release
TriLink BioTechnologies (TriLink®), a Maravai™ LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has signed a non-exclusive License and Supply Agreement with Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries. This agreement with Lonza strengthens TriLink’s objective to drive greater access to CleanCap® mRNA capping technologies as the demand for mRNA – a promising therapeutic modality – continues to grow. According to the terms of the agreement, TriLink® will supply its patented CleanCap® M6, CleanCap® AG 3’OMe, CleanCap® AG, and CleanCap® AU cap analogs for use in Lonza’s global mRNA development and manufacturing services, from pre-clinical through Phase III programs. CleanCap® technology is a one-pot solution with over 95% capping efficiency that streamlines mRNA production processes when compared to legacy capping methods. “CleanCap® technology is accelerating programs from discovery to
Debiopharm & Repare Therapeutics Announce First Patient Dosed in Phase 1/1b Mythic Trial Evaluating the Synthetic Lethal Combination of WEE1 AND PKMYT1 Inhibition30.4.2024 13:05:00 CEST | Press release
Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to cure cancer and infectious diseases, and Repare Therapeutics Inc. (“Repare”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, announced that the first patient has been dosed in Module 4 of the ongoing Phase 1/1b MYTHIC (NCT04855656) clinical trial, investigating the combination of Debio 0123 and lunresertib. In this trial, Debiopharm and Repare seek to assess the safety, pharmacokinetics, pharmacodynamics and preliminary clinical activity of this PKMYT1 and WEE1 inhibitor combination. In early January, Debiopharm and Repare announced a collaboration to evaluate the clinical combination of Debio 0123, an oral, brain-penetrant, highly selective WEE1 kinase inhibitor and lunresertib, a first-in-class, selective and potent oral small molecule inhibitor of PKMYT1. This collaboration is based on preclinical in vivo data and other da